Furthermore considering hypoplastic lungs, bombesin and ghrelin antagonists decreased RAR/ expression. RA, ghrelin plus RA, bombesin or ghrelin exhibited increased lung growth. Moreover, bombesin and ghrelin increased RAR/ expression levels, whereas the bombesin and ghrelin antagonists decreased RAR/ expression. This study demonstrates for the first time that neuroendocrine factors function as lung growth regulators, sensitising the lung to the action of RA through up-regulation of RAR and Mouse monoclonal to CDH2 RAR. Key points Retinoic acid (RA) and ghrelin levels are altered in human hypoplastic lungs USL311 when compared to healthy lungs. Although USL311 considerable data have been obtained about RA, ghrelin and bombesin in the congenital diaphragmatic hernia (CDH) rat model, neuroendocrine factors have never been associated with the RA signalling pathway in this animal model. In this study, the interaction between neuroendocrine factors and RA was explored in the CDH rat model. The authors found that normal fetal lung explants treated with RA, bombesin and ghrelin showed an increase in lung growth. Hypoplastic lungs presented higher expression levels of the RA receptors and . Moreover bombesin and ghrelin supplementation, shows representative examples of control fetal lung explants treated with bombesin (1?m), ghrelin (30?nm), RA (10?6?m), bombesin plus RA or ghrelin plus RA. In normal lungs, bombesin, ghrelin, RA and the combination of bombesin or ghrelin with RA appear to stimulate lung growth (Fig.?(Fig.2and confirmed through morphometric analysis (Fig.?(Fig.2and ?andand ?andand ?andand ?and7and ?andand ?andassays have shown that nitrofen inhibits Retinaldehyde dehydrogenase 2 (RALDH2) (Mendelsohn and ?andbombesin and ghrelin supplementation in hypoplastic lung explant cultures did not affect the examined lung morphometric parameters (Fig.?(Fig.2and ?andD),D), probably because these receptors are already overexpressed. The expression of RAR and RAR slightly decreases in hypoplastic lungs after ghrelin supplementation (Fig.?(Fig.3).3). We do not have a plausible explanation for this result. However, this finding reinforces the idea that there is an association between neuroendocrine factors and RA signalling. Moreover, inhibition of bombesin or ghrelin significantly decreased RAR expression as well as lung branching (Fig.?(Fig.7),7), reinforcing our hypothesis. It has largely been demonstrated that RA significantly increases lung branching in hypoplastic lungs after RA supplementation in vitro. Moreover, hypoplastic lungs overexpress bombesin and ghrelin (Cutz et?al. 2007). In this study, we observed an increase in RAR and RAR expression in hypoplastic lungs that might be explained by the compensatory overexpression of bombesin and ghrelin in these lungs (Fig.?(Fig.3).3). This is in agreement with the effect of neuroendocrine factor supplementation in normal lungs. In Fig.?Fig.8,8, a putative mechanism for the link between neuroendocrine cells and the RA pathway is presented. Open in a separate window Figure 8 Schematic representation of the putative link between neuroendocrine cells and the retinoic acid signalling pathway In the upper panel, on the left side of the scheme we have represented the normal fetal lung expressing neuroendocrine products: bombesin (Bomb) and ghrelin (Grl) as well as retinoic acid receptors (RAR). On USL311 the right side of the scheme we have represented the CDH fetal lungs, which express increased () levels of neuroendocrine products (Bomb and Grl) as well as RAR. On the bottom panel, we represent the RAR explants expression after modulation (agonists and antagonists) of neuroendocrine products. Focusing on isoform , in control explants, RAR() expression is significantly increased () and decreased () with addition of agonists (full arrows, Bomb and Grl) and antagonists (dashed arrows, Bomb Ant and Grl Ant) of neuroendocrine products, respectively. Regarding CDH explants, addition of neuroendocrine products does not induce and additionally increment RAR() expression when compared with untreated CDH explants (=), USL311 but addition of neuroendocrine antagonists (Bomb Ant and Grl Ant) induces a significant decrease () of RAR() expression. As a result of.